medigraphic.com
ISSN 1405-8871 (Print)

2016, Number 2

<< Back Next >>

Aten Fam 2016; 23 (2)

Prevalence of Therapeutic Adherence in Hypertensive Patients with the Use of the Martin-Bayarre-Grau Questionnaire

Maldonado-Reyes FJ, Vázquez-Martínez VH, Loera-Morales J, Ortega-Padrón M

Language: Spanish
References: 26
Page: 48-52
PDF size: 229.23 Kb.


ABSTRACT

Objective: to determine the prevalence of adherence of hypertensive patients in Reynosa, Tamaulipas, Mexico, from January to April 2011. Methods: observational, descriptive and cross-sectional study. 322 patients, attending the Mexican Social Security Institute (imss), assigned to the Family Medicine Unit no. 33 in Reynosa, Tamaulipas, were surveyed with diagnosis of Systemic Arterial Hypertension (sah), between 20 to 69 years old and with previous informed signed consent. Blood pressure was taken after 10 minutes of their arrival to the clinic and 10 minutes later. After that, the Matin-Bayarre-Grau questionnaire was applied. Results: 39% (126 patients) had total adherence to the treatment, 59% (190) had partial adherence and 2% had no adherence; 62.4% of the patients had less than 10 years hypertension. Conclusions: therapeutic adherence can be improved and therefore, Systemic Arterial Hypertension control in order to reduce complications of the disease in the long run.


REFERENCES

  1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-23.

  2. Public Health Agency of Canada. Report from the Canadian Chronic Disease Surveillance System: Hypertension in Canada, 2010. Ottawa(ON): The Agency [Internet]; 2011. Disponible en: www.phacaspc.gc.ca/cd-mccvd- mcv/ccdss-snsmc-2010/index-eng.php

  3. Barquera S, Campos-Nonato I, Hernandez- Barrera L et al. Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Pública Méx. 2010;52(supplement I):S63-S71.

  4. Lopez AD, Mathers CD. Measuring the global burden of disease and epidemiological transitions: 2002-2030. Ann Trop Med Parasitol. 2006;100:481-99.

  5. Rodgers A, Ezzati M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ. Distribution of major health risks: findings from the Global Burden of Disease study. PLoS Med. 2004;1(1):e27.

  6. O’Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao “Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case” control study. Lancet. 2010;376:112-23.

  7. Norma Oficial Mexicana. nom-030- SSA2-1999. Para la prevención, tratamiento y control de la hipertensión arterial. Diario Oficial de la Federación. 2001; enero 17.

  8. Secretaría de Salud. Guía de Práctica Clínica para el Diagnóstico y Tratamiento de la Hipertensión Arterial en el Primer Nivel de Atención. México: Secretaría de Salud; 2008.

  9. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-52.

  10. Zhang M, Meng Y, Yang Y, Liu Y, Dong C, Xiao J, et al. Major inducing factors of hypertensive complications and the interventions required to reduce their prevalence: an epidemiological study of hypertension in a rural population in China. bmc Public Health. 2011;11:301.

  11. Roumie CL, Ofner S, Ross JS, Arling G, Williams LS, Ordin DL, et al. Prevalence of inadequate blood pressure control among veterans after acute ischemic stroke hospitalization: a retrospective cohort. Circ Cardiovasc Qual Outcomes. 2011;4(4):399-407.

  12. Chew BH, Mastura I, Shariff-Ghazali S, Lee PY, Cheong At, Ahmad Z, et al. Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009. Cardiovasc Diabetol. [Internet] 2012;11:54. Disponible en: doi: 10.1186/1475-2840-11-54.

  13. Thoenes M, Bramlage P, Zhong S, Shang S, Volpe M, Spirk D. Hypertension control and cardiometabolic risk: a regional perspective. Cardiol Res Pract. 2012;2012:925046.

  14. Lindblad U, Ek J, Eckner J, Larsson CHA, Shan G, Rastam L. Prevalence, awareness, treatment, and control of hypertension: Rule of thirds in the Skaraborg project. Scandinavian Journal of Primary Health Care. 2012;30(2):88-94.

  15. Adherence to Long-Term Therapies-Evidence for Action who [Internet]; 2003. [Citado 2015 oct 13] Disponible en: http://apps.who.int/ medicinedocs/en/d/Js4883e/

  16. Osterberg L, Blaschke T. Adherence to medication. N. Engl J Med. 2005;353:487-97.

  17. Sabaté E. Adherencia a los tratamientos a largo plazo: Pruebas para la acción. Organización Mundial de la Salud/oms, 2004; traducción de la Organización Panamericana de la Salud/ops.

  18. Hill MN, Miller NH, DeGeest S. ASH position paper: Adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens. 2010;12:757-64.

  19. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190-6.

  20. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A metaanalysis of the association between adherence to drug therapy and mortality. bmj [Internet]; 2006;333:15-8. Disponible en: doi: 10.1136/ bmj.38875.675486.55.

  21. Martín L, Bayarre H, Grau J. Validación del cuestionario mbg (Martín- Bayarre-Grau) para evaluar la adherencia terapéutica en hipertensión arterial. Rev Cubana Salud Pública [Internet]. 2008 Mar [citado 31 May 2010];34(1). Disponible en: http://scielo.sld.cu/scielo. php?script=sci_arttext&pid=S0864- 34662008000100012&lng=es

  22. Tu Karen, Chen Zhongliang, Lipscombe LL. Prevalence and incidence of hypertension from 1995-2005. cmaj. 2008; 178(11):1429-35.

  23. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber L, Morisky DE, et al. Predictors of decline in medication adherence: Results from CoSMO. Hypertension. 2011; 58(5): 804-10.

  24. Kautzky-Willer A, Dorner T, Jensby A, Rieder A. Women show a closer association between educational level and hypertension or diabetes mellitus than males: A secondary analysis from the Austrian his. bmc Public Health. 2012;12:392.

  25. Karbach U, Schubert I, Hagemeister J, Ernstmann N, Pfaff H, Hopp HW. Physicians Knowledge of and Compliance with Guidelines: An exploratory study in cardiovascular diseases. Dtsch Arztebl Int. 2011;108(5):61-9.

  26. Rami A, Ahmad NS, Paraidathathu T. Medication adherence among hypertensive patients of primary health clinics in malasya. Patient Preference and Adherence. 2012;6:613-22.




2020     |     www.medigraphic.com